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Abstract
Twenty patients affected by bilateral occipital cortical-subcortical calcification (BOC) are described, 19 (95%) had epilepsy. In 8 of 16 cases studied, intestinal biopsy revealed coeliac disease. Fourteen patients had occipital partial epilepsy with a relatively benign outcome, while 4 patients were affected by a severe form of epilepsy, with very frequent, drug-resistant, generalised and partial seizures with mental deterioration. One patient had a single episode of convulsive status epilepticus at four months of age. The neurological examination was normal in all patients. CT showed flocculo-nodular, cortico-subcortical BOC, without enhancement and without lobar or hemispheric atrophy. MRI was normal. The clinical and neuroimaging features of these patients are different therefore from those with the Sturge-Weber Syndrome. The study confirms a high prevalence of coliac disease in patients with BOC, but the relationship between these two pathologies still needs to be clarified.
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The combination of epilepsy, bilateral occipital calcification (BOC) and coeliac disease (CD) is a recently described syndrome,'"3 whose clinical features and outcome have not been clearly defined.
We have traced reports of 36 patients 49 affected by epilepsy whose CT image was unusual in showing cortical and subcortical calcification (Ca) located in both occipital regions; in 14 of them CD was also detected. The occipital Ca were similar to those found in Sturge-Weber syndrome(SWs) but these patients showed none of the other typical symptoms of SWs: namely noevus flammeus, glaucoma and neurological deficit.
The aim of this study was to identify the clinical and neuroradiological features of the new syndrome and to clarify its distinction from SWs.
Material and methods Our study group was composed of 20 patients, 11 females and 9 males, all of whom were found to have BOC. The mean age was 14-6 years (range 6-23 years) and the mean follow up time was 9 5 years (range years). Each patient had complete ophthalmological and neurological examination, EEG and polygraphic recordings during wakefulness and sleep, and routine blood tests. In addition, we determined the blood levels of antiepileptic drugs, parathyroid hormone, calcitonin, and blood antibodies (TORCH complex). In 3 patients (cases 8, 9, and 15) blood folic acid level and serological HLA typing were also studied.
Sixteen patients had intestinal biopsy, whether or not they had clinical symptoms of malabsorption.
Cerebral CT was performed in all patients and repeated two or three times in 13 patients. Other special tests were performed as follows: skull radiographs (12 patients), MRI (8 patients), cerebral angioscintigraphy (5 patients), digital angiography (2 patients) and SPECT (2 patients).
Results
The main features of the 20 patients are summarised in the table.
Family history was irrelevant in 19 cases. One patient (case 8) had a sister affected by partial epilepsy, whose CT showed a unilateral calcification in the right occipital region.
Intellectual and neurological picture was normal in 19 patients. One patient (case 13) showed a bilateral reduction of the visual field.
Routine laboratory tests were normal in all patients. Folic acid level, tested in 2 patients affected by CD (cases 9 and 15) In this early stage EEG was available for only 10 of the 14 patients. It showed normal background activity and the presence of spikes and/or spikes and waves in one or both parieto-occipital regions, enhanced by eyes closure. These abnormalities were not activated during sleep. In patient 12 the EEG showed generalised spike and wave discharges.
The epilepsy did not follow the same course in all 14 patients: in 6 patients (cases 1, 4, 6, 8, 13 and 14) , now aged between six and 16 years, the seizures stopped after treatment, at a mean age of 5-9 years (range 2-15 years) and they have not recurred, though treatment with antiepileptic drugs had been discontinued. In cases 2, 3, 5, 9, and 12, now aged between and 23 years, the seizures disappeared at an average age of 5 6 years (range 3-7 5 years), but they recurred between six and 14 years, after an average seizure-free interval of 4-8 years (range 1-9 5 years). In cases 7, 10 and 11, seizures persisted in spite of the treatment.
Among those patients whose seizures persisted or recurred, the attacks remained partial (versive, visual or partial complex), one patient had more than one type of partial seizure. Cases 10, 11 and 12 also had convulsive generalised seizures. Seizure frequency was low on the antiepileptic drugs, with the exception of case 9, who continued to have several seizures a day, often induced by eating.
In the late phase, irrespective of the seizure outcome, the EEG showed the persistence of paroxysmal abnormalities in all but one case (case 2). These were localised to one or both posterior regions, and could take the form of pseudoperiodical asynchronous slow spikes or slow spike-slow wave complexes.
During sleep a marked bilateral spread of these abnormalities was observed, with the appearance of frequent bursts of diffuse slow spike-slow wave complexes.
Generalised and partial epilepsy Four patients had a severe form of epilepsy. The seizures appeared at a mean age of 5-2 years (range 1-9 years). At the onset 3 patients showed partial seizures, versive and/or visual, and 2 of these also had absences (cases 17 and 18). The fourth patient had both partial and generalised (tonic) seizures (case 16). At this early stage, neurological examination and intellectual level were normal in all patients. In all cases seizures were frequent at onset, occurring (16 and 17) , the seizures stopped after treatment, but recurred, after a seizure-free period of one year and five years respectively. There was a progressive deterioration of the seizures with time, with the appearance of polymorphous, partial and convulsive generalised seizures, and partial seizures with falls. Atypical absences were present in all cases. One patient also experienced prolonged complex partial status epilepticus. Seizures were frequent and drug-resistant in all cases. Concomitantly, intellectual deterioration occurred, while neurological examination remained unchanged.
EEG was distinctly pathological in all cases, showing bilateral and asynchronous slow spike and slow wave complexes in both temporo-parieto-occipital regions and long bursts of secondarily diffused slow spike and slow wave complexes. These abnormalities were clearly enhanced by eye closure and were attenuated by eye opening. The multifocal and diffuse abnormalities, observed during wakefulness, persisted during sleep and diffuse discharges of fast polyspikes-slow wave complexes appeared. In 2 of these 5 patients the diet, begun three and five years respectively after seizure onset, had no effect on seizure frequency. For the other 3 patients no details regarding the administration of the diet were available.
Of the 8 patients in whom intestinal biopsy was normal, two presented symptoms of malabsorption during infancy. Neither had ever been on a gluten-free regime (cases 3 and 6).
The malabsorption symptoms appeared before epileptic seizures in all but one of the patients.
Discussion
Nineteen of the 20 patients (95%) affected by BOC had epilepsy, and many of them (50%) had a malabsorption syndrome. It is therefore clear that they form a clinical syndrome.
The symptom which led to neuroradiological investigations was epilepsy, but the clinical picture of this process is variable. We have been able to identify 2 groups of patients with quite different clinical courses: the first group (14 patients) had partial epilepsy with occipital seizures. In these cases the epilepsy was particularly active in the early phase, during which status epilepticus also occurred, but it has a relatively benign prognosis. Sometimes the seizures disappeared entirely, sometimes recurred after a long seizure-free interval, and sometimes persisted at a low frequency. In all cases the intellectual level and the neurological examination remained normal; the second group (4 patients) had an onset of epilepsy characterised by partial occipital seizures. After an initial phase, and with or without the seizure-free interval, frequent, polymorphous and drug-resistant seizures developed. These patients all showed concomitant intellectual deterioration.
The evolution of this second group is similar to that reported in some cases of BOC9 and in particular by Gobbi et al. ' Partial occipital epilepsy which evolves towards a pattern of epileptic encephalopathy has also been observed in patients with occipital calcifications due to toxoplasmosis or therapy with intrathecal methotrexate and cranial irradiation, as well as in patients showing no occipital calcification. 20 The factors which determine such an important difference in evolution between our two groups are not clear: there is no difference in mean age of onset of the epilepsy; there is no correlation between the seriousness of the epilepsy and the extent of the calcification; there is no clear correlation between the seriousness of the epilepsy and the presence or absence of CD. BOC and CD, and it is not present in patients with BOC who do not have CD.
The high prevalence of CD in patients with BOC is reminiscent of the association between CD and dermatitis herpetiformis (DH) . All or almost all the patients affected by DH also have CD, clinical or subclinical, while only a limited number of patients with CD have DH.38 As in CD without skin lesions, the prevalence of the histocompatibility antigens HIA-B8, and H1A-DQw2 is much higher in patients with DH than in normal individuals. This suggests that DH and CD are two distinct diseases, probably connected by the same genetic factor. 39 HLA studies were carried out in only 3 of our patients, 2 with CD and 1 without. They all showed the presence of the histocompatibility antigens HIA-DR7 and DQw2, which are strongly associated with the susceptibility to CD.40 These preliminary findings suggest that a similar HIA pattern may cause the susceptibility both for CD and BOC.
Conclusions
Patients with BOC have epilepsy which can vary from partial epilepsy, confined to the first years of life, to serious long lasting epilepsy and intellectual deterioration.
Patients with BOC are clearly distinguishable from those with SWs not only on the clinical level, but also on the basis of neuroimaging.
The high prevalance of a malabsorption syndrome in patients with BOC is established, but the causal relationship between these two pathologies stil needs to be clarified.
It seems justifiable therefore to consider the association of BOC, epilepsy and, in some cases CD, as a distinct entity.
